News & Commentary
Latest News Features
- Biopharmaceutical company Epizyme sets terms for $60 million IPO
- Eaton Vance Senior Floating-Rate Fund (EFR) Ex-Dividend Date Scheduled for May 22, 2013
- Eaton Vance Tax-Managed Diversified Equity Income Fund (ETY) Ex-Dividend Date Scheduled for May 22, 2013
- Flaherty & Crumrine Preferred Securities Income Fund Inc (FFC) Ex-Dividend Date Scheduled for May 22, 2013
Latest News Videos
Moving the Market |
|
Market Summary | | Stocks On The Move |
5/21/2013 1:30 PM ET
[BRIEFING.COM][BRIEFING.COM] The S&P 500 trades higher by 0.4% after climbing to a fresh session best. The recent gains occurred as the weakest sectors of the day returned into positive territory. The defensively-oriented telecom space has been the lone...[more]
Stock Market Headlines
MARKET SNAPSHOT: U.S. Stocks Rise After Fed Officials Comments 1:37PM ET - Dow Jones Business News
EveryWare Global, Inc. and ROI Acquisition Corp. Complete Business Combination 1:35PM ET - GlobeNewswire
Clearwire Special Meeting of Stockholders Rescheduled for May 31, 2013 1:35PM ET - GlobeNewswire
Resolution to Split Chairman, CEO at J.P. Morgan Fails 1:25PM ET - Dow Jones Business News
Correction to Embraer Lands Another Major Order Story 1:19PM ET - Dow Jones Business News
View AllBrowse News by Category
RSS user?
Market Currents
Real-time news and commentary for investors
- 1:50 PM Biogen ([[BIIB]] +3.6%) submits Biologics License Application to the FDA for the approval of its injectable drug candidate Plegridy for the treatment of multiple sclerosis. The company says the application is supported by data from year one of a two year Phase 3 study which "met all primary and secondary endpoints." In March, BIIB said the drug cut annual relapse rates by 36% and analysts say it could generate revenue of $318M by 2017. ( PR)
- See All Market Currents
Most Popular Stories
- First Subpoenas Issued in Spam Email Pump & Dump Lawsuit Against Xumanii and Publishers of "Awesome Penny Stocks" and "Select Penny Stocks" Newsletters
- MARKET SNAPSHOT: Stock Rally's Breadth Is A Sign Of Strength, Froth
- Analysts See Close Vote in Showdown Over Dimon's Dual Roles
- Brazil Opposition PSDB Picks Aecio Neves as Party President
- U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH